Armis Advisers’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$529K Buy
33,077
+503
+2% +$7.72K 0.05% 264
2026
Q1
$512K Buy
32,574
+536
+2% +$7.89K 0.05% 243
2025
Q4
$457K Sell
32,038
-9,494
-23% -$137K 0.05% 243
2025
Q3
$611K Sell
41,532
-1,570
-4% -$23.5K 0.06% 176
2025
Q2
$655K Buy
43,102
+17,657
+69% +$258K 0.05% 242
2025
Q1
$366K Buy
+25,445
New +$389K 0.03% 285

Other funds holding BCAT

Armis Advisers's BCAT Position: Q2 2026 in Review

Armis Advisers increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 1.5% in Q2 2026, buying an estimated $7.72K and bringing the position to 33,077 shares worth $529K. The position accounts for 0.05% of the portfolio, ranked #264.

Armis Advisers first reported a position in BCAT in Q1 2025 and has held it in 6 quarters since. The position peaked at $655K in Q2 2025. 12 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.

  • Armis Advisers held 33,077 shares of BlackRock Capital Allocation Term Trust worth $529K as of Q2 2026.
  • Armis Advisers bought 503 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $7.72K.
  • BlackRock Capital Allocation Term Trust made up 0.05% of Armis Advisers's portfolio in Q2 2026, its #264 holding.
  • Armis Advisers first reported a position in BlackRock Capital Allocation Term Trust in Q1 2025 and has held it in 6 quarters since.
  • Armis Advisers's BlackRock Capital Allocation Term Trust position peaked at $655K in Q2 2025.
  • 12 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.

Based on Armis Advisers's 13F filing for Q2 2026, filed 7 Jul 2026.